/Investor DB

Ascension Ventures — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Cofactor Genomicscofactorgenomics.comin𝕏Series A · Dec 2025 · $18M

Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response.

AI & Machine LearningBiotechHealthtechMedical DevicesSt. Louis, US

Dave Messina(COO)inJarret Glasscock(CTO)inJarret Glassock(Executive Officer, Director)Jon Armstrong(COO)inJonathan Wald(Software Engineering Intern)

BoardMatthew A. Ocko(Director)in

Co-investorsArgonautic VenturesBioGenerator VenturesDCVC (Data Collective)Fifty YearsiSelect FundJude Gomila+11 more

Hesta Healthhestahealth.cominJul 2025

Hesta Health delivers comprehensive postnatal care to women and birthing parents in the two years following childbirth, combining clinical expertise with technology to improve recovery and lifelong health outcomes.

Digital HealthFemTechHealthtech

Sujitha(Co-founder)inAmanda Cupples(Co-founder)in

Co-investorsAscensionBlue LionBlue Lion GlobalEka VenturesSamos Investments

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.